Karyopharm Therapeutics Inc. (KPTI) Revenue History
Karyopharm Therapeutics Inc. (KPTI) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2016-12-31 | $154.00K |
| 2017-12-31 | $1.60M |
| 2018-12-31 | $30.34M |
| 2019-12-31 | $40.89M |
| 2020-12-31 | $108.08M |
| 2021-12-31 | $209.82M |
| 2022-12-31 | $157.07M |
| 2023-12-31 | $146.03M |
| 2024-12-31 | $145.24M |
| 2025-12-31 | $146.07M |
How KPTI compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| HRTX | Heron Therapeutics Inc. | $154.90M |
| STIM | Neuronetics Inc. | $149.16M |
| QTRX | Quanterix Corporation | $138.90M |
| NRC | National Research Corporation | $137.39M |
| OSUR | OraSure Technologies Inc. | $115.02M |
These are five companies in the same sector as KPTI with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Karyopharm Therapeutics Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("KPTI", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | KPTI | $1.96 | +7.69% | 0.88M |
| 3 | ||||
| 4 | ||||
| 5 |